Taysha Gene Therapies, Inc. (TSHA)
Nasdaq: TSHA · CIK 0001806310 · United States
Every official Taysha Gene Therapies, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open TSHA filings
Taysha Gene Therapies, Inc. documents
- Taysha Gene Therapies, Inc. 10-K 2026TSHA 10-K 2026: annual report for fiscal 2026
- Taysha Gene Therapies, Inc. 10-K 2025TSHA 10-K 2025: annual report for fiscal 2025
- Taysha Gene Therapies, Inc. 10-K 2024TSHA 10-K 2024: annual report for fiscal 2024
- Taysha Gene Therapies, Inc. 10-K 2023TSHA 10-K 2023: annual report for fiscal 2023
- Taysha Gene Therapies, Inc. 10-K 2022TSHA 10-K 2022: annual report for fiscal 2022
- Taysha Gene Therapies, Inc. 10-Q 2026TSHA 10-Q 2026: quarterly report for fiscal 2026
- Taysha Gene Therapies, Inc. 10-Q 2025TSHA 10-Q 2025: quarterly report for fiscal 2025
- Taysha Gene Therapies, Inc. 10-Q 2024TSHA 10-Q 2024: quarterly report for fiscal 2024
- Taysha Gene Therapies, Inc. 10-Q 2023TSHA 10-Q 2023: quarterly report for fiscal 2023
- Taysha Gene Therapies, Inc. 10-Q 2022TSHA 10-Q 2022: quarterly report for fiscal 2022
- Taysha Gene Therapies, Inc. 8-K 2026TSHA 8-K 2026: current report for fiscal 2026
- Taysha Gene Therapies, Inc. 8-K 2025TSHA 8-K 2025: current report for fiscal 2025
- Taysha Gene Therapies, Inc. 8-K 2024TSHA 8-K 2024: current report for fiscal 2024
- Taysha Gene Therapies, Inc. 8-K 2023TSHA 8-K 2023: current report for fiscal 2023
- Taysha Gene Therapies, Inc. 8-K 2022TSHA 8-K 2022: current report for fiscal 2022
- Taysha Gene Therapies, Inc. DEF 14A 2026TSHA DEF 14A 2026: proxy statement for fiscal 2026
- Taysha Gene Therapies, Inc. DEF 14A 2025TSHA DEF 14A 2025: proxy statement for fiscal 2025
- Taysha Gene Therapies, Inc. DEF 14A 2024TSHA DEF 14A 2024: proxy statement for fiscal 2024
- Taysha Gene Therapies, Inc. DEF 14A 2023TSHA DEF 14A 2023: proxy statement for fiscal 2023
- Taysha Gene Therapies, Inc. DEF 14A 2022TSHA DEF 14A 2022: proxy statement for fiscal 2022
- Taysha Gene Therapies, Inc. Form 4 2026TSHA Form 4 2026: insider trading filing for fiscal 2026
- Taysha Gene Therapies, Inc. Form 4 2025TSHA Form 4 2025: insider trading filing for fiscal 2025
- Taysha Gene Therapies, Inc. Form 4 2024TSHA Form 4 2024: insider trading filing for fiscal 2024
- Taysha Gene Therapies, Inc. Form 4 2023TSHA Form 4 2023: insider trading filing for fiscal 2023
- Taysha Gene Therapies, Inc. Form 4 2022TSHA Form 4 2022: insider trading filing for fiscal 2022
- Taysha Gene Therapies, Inc. S-1 2026TSHA S-1 2026: registration statement for fiscal 2026
- Taysha Gene Therapies, Inc. S-1 2025TSHA S-1 2025: registration statement for fiscal 2025
- Taysha Gene Therapies, Inc. S-1 2024TSHA S-1 2024: registration statement for fiscal 2024
- Taysha Gene Therapies, Inc. S-1 2023TSHA S-1 2023: registration statement for fiscal 2023
- Taysha Gene Therapies, Inc. S-1 2022TSHA S-1 2022: registration statement for fiscal 2022
- Taysha Gene Therapies, Inc. 13F 2026TSHA 13F 2026: institutional holdings for fiscal 2026
- Taysha Gene Therapies, Inc. 13F 2025TSHA 13F 2025: institutional holdings for fiscal 2025
- Taysha Gene Therapies, Inc. 13F 2024TSHA 13F 2024: institutional holdings for fiscal 2024
- Taysha Gene Therapies, Inc. 13F 2023TSHA 13F 2023: institutional holdings for fiscal 2023
- Taysha Gene Therapies, Inc. 13F 2022TSHA 13F 2022: institutional holdings for fiscal 2022
More companies